Diphenhydramine and magnesium salicylate and Omalizumab Subcutaneous
Determining the interaction of Diphenhydramine and magnesium salicylate and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: diphenhydramine / magnesium salicylate
Brand name: Doans PM
Synonyms: n.a.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Diphenhydramine and magnesium salicylate-Ombitasvir, Paritaprevir, and Ritonavir
- Diphenhydramine and magnesium salicylate-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Diphenhydramine and magnesium salicylate-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Diphenhydramine and magnesium salicylate-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Diphenhydramine and magnesium salicylate-Omeclamox-Pak
- Diphenhydramine and magnesium salicylate-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Diphenhydramine and phenylephrine
- Omalizumab Subcutaneous-Diphenhydramine and Phenylephrine Liquid, Solution, and Syrup
- Omalizumab Subcutaneous-Diphenhydramine and Phenylephrine Oral Strips
- Omalizumab Subcutaneous-Diphenhydramine Capsules
- Omalizumab Subcutaneous-Diphenhydramine Capsules and Tablets
- Omalizumab Subcutaneous-Diphenhydramine Chewable Tablets and Orally-Disintegrating Tablets